MEDICAL SERVICES

Specialties

Departments

Programs

Languages

  • German

  • French

  • English

EDUCATION

Medical School

  • Westfalische Wilhelms-Universitat , 1999 , Munster , Germany

Internship

Pediatrics
  • Cleveland Clinic , 2004 , Cleveland , OH

Residency

Neurology
  • Westfalische Wilhelms-Universitat , 2000 , Munster , Germany

Residency

Pediatrics
  • Cleveland Clinic , 2005 , Cleveland , OH

Residency

Child Neurology
  • Cleveland Clinic , 2008 , Cleveland , OH

Fellowship

Epilepsy & Clinical Neurophysiology
  • Cleveland Clinic , 2003 , Cleveland , OH

Philosophy of Care

Within my Area of Excellence in Investigation I have an outstanding record of successful and productive research in areas of high relevance for our pediatric epilepsy population.  My expertise and experience as an innovator and teacher place me in an excellent position to continue to make important contributions to the field directly, as well as to exert future influence in the field through the researchers I train.

PROFESSIONAL HISTORY

As a pediatrician, pediatric neurologist, and clinical neurophysiologist, with specific training in seizure monitoring and treatment, I spend approximately 40% of my time in investigation, 20% in direct clinical care, 10% in teaching activities, and 30% in significant supporting activities. My early research experience as a resident and fellow included observational and interventional studies on clinical seizure manifestations and treatment. Following my 2008 appointment as Assistant in Neurology at Boston Children’s Hospital, I expanded my research to include circadian variation of seizures and used this information to develop a patient-oriented medication treatment schedule. My research is focused on identifying the factors that determine epileptic encephalopathies and status epilepticus as well as functional outcome later in life. Repetitive seizures and epileptic encephalopathy can impair development, plasticity and cognitive function of eloquent areas including language and memory. Seizure frequency reduction and seizure freedom, in particular after epilepsy surgery, have been shown to improve neurocognitive and developmental outcome. By identifying biomarkers that indicate predictors of cerebral damage and developmental outcome in epileptic encephalopathies and status epilepticus, we intend to reduce the occurrence of brain damage and later developmental disabilities and aim to identify novel therapeutic approaches.

What are we doing?

- Comparative effectiveness and interventional clinical trials in pediatric status epilepticus and epileptic encephalopathies

 

How do we do it?

Inventing, evaluating and implementing clinically relevant biomarkers and treatment paradigms to assess and benchmark these based on clinical data, neurophysiology, imaging, pharmacogenomics and genetics, in collaboration with basic researcher locally, nationally, and internationally.

Developing and evaluating monitoring tools for clinical biomarkers to further clinical epilepsy outcome measures including seizure characterization, neuropsychological outcome assessment, and quality of life assessment by means of seizure sensors and electronic tools including ICISS, the RENCI seizure tracking and outcome prediction modeling software, and novel in- and outpatient monitoring devices and algorithms, and neurophysiological, biochemical and genetic periodicity markers and implement these techniques into clinical workflow.

Research networks and collaborations are essential for our work, like the pediatric status epilepticus research group (www.pserg.org), the Pediatric Epilepsy Research Consortium , the pediatric critical care epilepsy research group, the Critical Care EEG consortium, the pediatric neurocritical care research group and other consortia.

CERTIFICATIONS

  • American Board of Psychiatry and Neurology, Child and Adolescent Neurology
  • American Board of Psychiatry and Neurology, Epilepsy

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications. Brain. 2021 Aug 25. View abstract
  2. Wearable devices for seizure detection: Practical experiences and recommendations from the Wearables for Epilepsy And Research (WEAR) International Study Group. Epilepsia. 2021 Aug 22. View abstract
  3. Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus. Epilepsia. 2021 Aug 21. View abstract
  4. Association between semiologic, autonomic, and electrographic seizure characteristics in children with generalized tonic-clonic seizures. Epilepsy Behav. 2021 Sep; 122:108228. View abstract
  5. EEG Biomarkers of Repository Corticotropin Injection Treatment. J Clin Neurophysiol. 2021 Aug 06. View abstract
  6. Video-Based Detection of Generalized Tonic-Clonic Seizures Using Deep Learning. IEEE J Biomed Health Inform. 2021 08; 25(8):2997-3008. View abstract
  7. Comparative Effectiveness of Initial Treatment for Infantile Spasms in a Contemporary US Cohort. Neurology. 2021 Jul 15. View abstract
  8. Seizure detection using wearable sensors and machine learning: Setting a benchmark. Epilepsia. 2021 Aug; 62(8):1807-1819. View abstract
  9. Factors associated with long-term outcomes in pediatric refractory status epilepticus. Epilepsia. 2021 Sep; 62(9):2190-2204. View abstract
  10. Super-Refractory Status Epilepticus in Children: A Retrospective Cohort Study. Pediatr Crit Care Med. 2021 Jun 14. View abstract
  11. Measuring the effects of sleep on epileptogenicity with multifrequency entropy. Clin Neurophysiol. 2021 Sep; 132(9):2012-2018. View abstract
  12. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort). Epilepsia. 2021 Jul; 62(7):1629-1642. View abstract
  13. Prediction of Seizure Recurrence. A Note of Caution. Front Neurol. 2021; 12:675728. View abstract
  14. Time to Treatment in Pediatric Convulsive Refractory Status Epilepticus: The Weekend Effect. Pediatr Neurol. 2021 Jul; 120:71-79. View abstract
  15. Author Response: Association of Guideline Publication and Delays to Treatment in Pediatric Status Epilepticus. Neurology. 2021 03 09; 96(10):503. View abstract
  16. Evaluation and recommendations for effective data visualization for seizure forecasting algorithms. JAMIA Open. 2021 Jan; 4(1):ooab009. View abstract
  17. Twenty-four-hour patterns in electrodermal activity recordings of patients with and without epileptic seizures. Epilepsia. 2021 Apr; 62(4):960-972. View abstract
  18. Efficacy and Tolerability of Rufinamide in Epileptic Children Younger Than 4 Years. J Child Neurol. 2021 03; 36(4):281-287. View abstract
  19. Status Epilepticus-Work-Up and Management in Children. Semin Neurol. 2020 12; 40(6):661-674. View abstract
  20. Machine learning from wristband sensor data for wearable, noninvasive seizure forecasting. Epilepsia. 2020 12; 61(12):2653-2666. View abstract
  21. The burden of decisional uncertainty in the treatment of status epilepticus. Epilepsia. 2020 10; 61(10):2150-2162. View abstract
  22. First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020 11 10; 95(19):e2683-e2696. View abstract
  23. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Curr. 2020 Sep; 20(5):245-264. View abstract
  24. Photoplethysmography: A measure for the function of the autonomic nervous system in focal impaired awareness seizures. Epilepsia. 2020 08; 61(8):1617-1626. View abstract
  25. Retrospective observational study on hospital readmission for status epilepticus in the United States over 2016. Epilepsia. 2020 07; 61(7):1386-1396. View abstract
  26. Autonomic nervous system changes detected with peripheral sensors in the setting of epileptic seizures. Sci Rep. 2020 07 14; 10(1):11560. View abstract
  27. Photoplethysmographic evaluation of generalized tonic-clonic seizures. Epilepsia. 2020 08; 61(8):1606-1616. View abstract
  28. EEG features of brain injury during extracorporeal membrane oxygenation in children. Neurology. 2020 09 08; 95(10):e1372-e1380. View abstract
  29. Slow wave activity during NREM sleep in patients with electrical status epilepticus in sleep. Seizure. 2020 08; 80:257-258. View abstract
  30. Association of guideline publication and delays to treatment in pediatric status epilepticus. Neurology. 2020 09 01; 95(9):e1222-e1235. View abstract
  31. Nonlinear Analysis of Visually Normal EEGs to Differentiate Benign Childhood Epilepsy with Centrotemporal Spikes (BECTS). Sci Rep. 2020 05 21; 10(1):8419. View abstract
  32. Mortality in infantile spasms: A hospital-based study. Epilepsia. 2020 04; 61(4):702-713. View abstract
  33. Electrocardiographic changes associated with epilepsy beyond heart rate and their utilization in future seizure detection and forecasting methods. Clin Neurophysiol. 2020 04; 131(4):866-879. View abstract
  34. Pharmacotherapy for Pediatric Convulsive Status Epilepticus. CNS Drugs. 2020 01; 34(1):47-63. View abstract
  35. Seizure prediction and intervention. Neuropharmacology. 2020 08 01; 172:107898. View abstract
  36. Novel treatment approaches and pediatric research networks in status epilepticus. Epilepsy Behav. 2019 12; 101(Pt B):106564. View abstract
  37. Estimating the cost of status epilepticus admissions in the United States of America using ICD-10 codes. Seizure. 2019 Oct; 71:295-303. View abstract
  38. Electroencephalographic Reporting for Refractory Status Epilepticus. J Clin Neurophysiol. 2019 Sep; 36(5):365-370. View abstract
  39. Bone Health Screening Practices Among Neurologists in Patients on Antiepileptic Drugs: A Quality Improvement Project. Pediatr Neurol. 2020 01; 102:49-55. View abstract
  40. The onset of pediatric refractory status epilepticus is not distributed uniformly during the day. Seizure. 2019 Aug; 70:90-96. View abstract
  41. Immediate outcomes in early life epilepsy: A contemporary account. Epilepsy Behav. 2019 08; 97:44-50. View abstract
  42. Encephalopathy related to Status Epilepticus during slow Sleep: from concepts to terminology. Epileptic Disord. 2019 Jun 01; 21(S1):5-12. View abstract
  43. Encephalopathy with continuous spike-waves during slow-wave sleep: evolution and prognosis. Epileptic Disord. 2019 Jun 01; 21(S1):15-21. View abstract
  44. Automated detection of sudden unexpected death in epilepsy risk factors in electronic medical records using natural language processing. Epilepsia. 2019 06; 60(6):1209-1220. View abstract
  45. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology. 2019 05 14; 92(20):e2339-e2348. View abstract
  46. Peripheral multimodal monitoring of ANS changes related to epilepsy. Epilepsy Behav. 2019 07; 96:69-79. View abstract
  47. Seizure Prediction Models in the Neonatal Intensive Care Unit. J Clin Neurophysiol. 2019 May; 36(3):186-194. View abstract
  48. Characteristics of Future Models of Integrated Outpatient Care. Healthcare (Basel). 2019 Apr 27; 7(2). View abstract
  49. New onset refractory status epilepticus research: What is on the horizon? Neurology. 2019 04 23; 92(17):802-810. View abstract
  50. Outcome of ambulatory video-EEG monitoring in a ˜10,000 patient nationwide cohort. Seizure. 2019 Mar; 66:104-111. View abstract
  51. Timely Interventions for Children with ADHD through Web-Based Monitoring Algorithms. Diseases. 2019 Feb 07; 7(1). View abstract
  52. Using EHRs to advance epilepsy care. Neurol Clin Pract. 2019 Feb; 9(1):83-88. View abstract
  53. Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study. Neurology. 2019 Jan 04. View abstract
  54. Chronotherapeutic implications of cyclic seizure patterns. Nat Rev Neurol. 2018 Dec; 14(12):696-697. View abstract
  55. KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect. Ann Neurol. 2018 11; 84(5):766-780. View abstract
  56. Circadian rhythm and epilepsy. Lancet Neurol. 2018 12; 17(12):1098-1108. View abstract
  57. Status epilepticus prevention, ambulatory monitoring, early seizure detection and prediction in at-risk patients. Seizure. 2019 May; 68:31-37. View abstract
  58. Caring electronically for young outpatients who have epilepsy. Epilepsy Behav. 2018 10; 87:226-232. View abstract
  59. Long-term outcomes of status epilepticus: A critical assessment. Epilepsia. 2018 10; 59 Suppl 2:155-169. View abstract
  60. Estimating the cost of admissions related to convulsive status epilepticus in the United States of America. Seizure. 2018 Oct; 61:186-198. View abstract
  61. Neuroimaging of Early Life Epilepsy. Pediatrics. 2018 09; 142(3). View abstract
  62. Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. Pediatr Neurol. 2018 09; 86:33-41. View abstract
  63. Automating Interictal Spike Detection: Revisiting A Simple Threshold Rule. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul; 2018:299-302. View abstract
  64. Timing in the treatment of status epilepticus: From basics to the clinic. Seizure. 2019 May; 68:22-30. View abstract
  65. Machine Learning for Outcome Prediction in Electroencephalograph (EEG)-Monitored Children in the Intensive Care Unit. J Child Neurol. 2018 07; 33(8):546-553. View abstract
  66. Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus. Epilepsy Res. 2018 08; 144:1-6. View abstract
  67. Different as night and day: Patterns of isolated seizures, clusters, and status epilepticus. Epilepsia. 2018 05; 59(5):e73-e77. View abstract
  68. Towards acute pediatric status epilepticus intervention teams: Do we need "Seizure Codes"? Seizure. 2018 May; 58:133-140. View abstract
  69. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus. Neurology. 2018 05 08; 90(19):e1692-e1701. View abstract
  70. Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus. JAMA Neurol. 2018 04 01; 75(4):410-418. View abstract
  71. Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy. JAMA Pediatr. 2018 04 01; 172(4):352-360. View abstract
  72. Common data elements for epilepsy mobile health systems. Epilepsia. 2018 05; 59(5):1020-1026. View abstract
  73. Can a collaborative healthcare network improve the care of people with epilepsy? Epilepsy Behav. 2018 05; 82:189-193. View abstract
  74. Conscious control of breathing: A key to prevention of sudden unexpected death in epilepsy? Ann Neurol. 2018 03; 83(3):449-450. View abstract
  75. Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms. PLoS One. 2018; 13(3):e0193599. View abstract
  76. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia. 2018 04; 59(4):745-752. View abstract
  77. Patterns of epileptic seizure occurrence. Brain Res. 2019 01 15; 1703:3-12. View abstract
  78. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018 04; 59(4):739-744. View abstract
  79. Should patients with complex febrile seizure be admitted for further management? Am J Emerg Med. 2018 08; 36(8):1386-1390. View abstract
  80. Devices for Ambulatory Monitoring of Sleep-Associated Disorders in Children with Neurological Diseases. Children (Basel). 2017 Dec 25; 5(1). View abstract
  81. The Need for Antiepileptic Drug Chronotherapy to Treat Selected Childhood Epilepsy Syndromes and Avert the Harmful Consequences of Drug Resistance. J Cent Nerv Syst Dis. 2017; 9:1179573516685883. View abstract
  82. Sleep patterns predictive of daytime challenging behavior in individuals with low-functioning autism. Autism Res. 2018 02; 11(2):391-403. View abstract
  83. New-Onset Status Epilepticus in Pediatric Patients: Causes, Characteristics, and Outcomes. Pediatr Neurol. 2018 03; 80:61-69. View abstract
  84. Response to clobazam in continuous spike-wave during sleep. Dev Med Child Neurol. 2018 03; 60(3):283-289. View abstract
  85. Time to continuous electroencephalogram in repeated admissions to the pediatric intensive care unit. Seizure. 2018 Jan; 54:19-26. View abstract
  86. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium. Epilepsia. 2017 12; 58(12):2098-2103. View abstract
  87. Behaviorally-determined sleep phenotypes are robustly associated with adaptive functioning in individuals with low functioning autism. Sci Rep. 2017 10 27; 7(1):14228. View abstract
  88. Rescue Medications in Epilepsy Patients: A Family Perspective. Seizure. 2017 Nov; 52:188-194. View abstract
  89. Multicenter clinical assessment of improved wearable multimodal convulsive seizure detectors. Epilepsia. 2017 11; 58(11):1870-1879. View abstract
  90. Continuous EEG in Pediatric Critical Care: Yield and Efficiency of Seizure Detection. J Clin Neurophysiol. 2017 Sep; 34(5):421-426. View abstract
  91. Early-Life Epilepsies and the Emerging Role of Genetic Testing. JAMA Pediatr. 2017 09 01; 171(9):863-871. View abstract
  92. Novel clinical manifestations in patients with KCNA2 mutations. Seizure. 2017 Oct; 51:74-76. View abstract
  93. Disparities in epilepsy surgery in the United States of America. J Neurol. 2017 Aug; 264(8):1735-1745. View abstract
  94. Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy. Epilepsia. 2017 09; 58(9):1575-1585. View abstract
  95. Electrographic Seizures in Preterm Neonates in the Neonatal Intensive Care Unit. J Child Neurol. 2017 Sep; 32(10):880-885. View abstract
  96. A Question Worth Asking. J Clin Neurophysiol. 2017 Jul; 34(4):392. View abstract
  97. Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus. Pediatr Neurol. 2017 Oct; 75:73-79. View abstract
  98. Nonintravenous rescue medications for pediatric status epilepticus: A cost-effectiveness analysis. Epilepsia. 2017 08; 58(8):1349-1359. View abstract
  99. Diagnostic and Therapeutic Management of a First Unprovoked Seizure in Children and Adolescents With a Focus on the Revised Diagnostic Criteria for Epilepsy. J Child Neurol. 2017 07; 32(8):774-788. View abstract
  100. Use of EEG in critically ill children and neonates in the United States of America. J Neurol. 2017 Jun; 264(6):1165-1173. View abstract
  101. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017 May 01; 140(5):1316-1336. View abstract
  102. Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals. J Child Neurol. 2017 06; 32(7):638-646. View abstract
  103. Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression. Ann Neurol. 2017 Mar; 81(3):419-429. View abstract
  104. Understanding Death in Children With Epilepsy. Pediatr Neurol. 2017 05; 70:7-15. View abstract
  105. Time to electroencephalography is independently associated with outcome in critically ill neonates and children. Epilepsia. 2017 03; 58(3):420-428. View abstract
  106. Reduced thalamic volume in patients with Electrical Status Epilepticus in Sleep. Epilepsy Res. 2017 02; 130:74-80. View abstract
  107. Refractory status epilepticus in children with and without prior epilepsy or status epilepticus. Neurology. 2017 Jan 24; 88(4):386-394. View abstract
  108. Seizures caused by brain tumors in children. Seizure. 2017 Jan; 44:98-107. View abstract
  109. Texting Rhythm With Temporal Predominance. J Clin Neurophysiol. 2016 Dec; 33(6):570. View abstract
  110. Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital. Pediatr Crit Care Med. 2016 10; 17(10):968-975. View abstract
  111. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort. Epilepsia. 2016 11; 57(11):1834-1842. View abstract
  112. Interictal epileptiform discharges and cognition. Dev Med Child Neurol. 2017 01; 59(1):13-14. View abstract
  113. HHV-6 and seizure: A systematic review and meta-analysis. J Med Virol. 2017 01; 89(1):161-169. View abstract
  114. The future of medicine will be dark without international collaboration [corrected]. Seizure. 2016 10; 41:42. View abstract
  115. Automated seizure detection systems and their effectiveness for each type of seizure. Seizure. 2016 Aug; 40:88-101. View abstract
  116. Real-time multi-channel monitoring of burst-suppression using neural network technology during pediatric status epilepticus treatment. Clin Neurophysiol. 2016 08; 127(8):2820-2831. View abstract
  117. Clobazam higher-evening differential dosing as an add-on therapy in refractory epilepsy. Seizure. 2016 Aug; 40:1-6. View abstract
  118. 2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. Epilepsy Curr. 2016 May-Jun; 16(3):192-7. View abstract
  119. Effectiveness of once-daily high-dose ACTH for infantile spasms. Epilepsy Behav. 2016 06; 59:4-8. View abstract
  120. Development and Feasibility Testing of a Critical Care EEG Monitoring Database for Standardized Clinical Reporting and Multicenter Collaborative Research. J Clin Neurophysiol. 2016 Apr; 33(2):133-40. View abstract
  121. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016 Mar; 79(3):475-84. View abstract
  122. Effectiveness of antiepileptic therapy in patients with PCDH19 mutations. Seizure. 2016 Feb; 35:106-10. View abstract
  123. Yield of emergent neuroimaging in children with new-onset seizure and status epilepticus. Seizure. 2016 Feb; 35:4-10. View abstract
  124. aEEG and cEEG: Two complementary techniques to assess seizures and encephalopathy in neonates: Editorial on "Amplitude-integrated EEG for detection of neonatal seizures: A systematic review" by Rakshasbhuvankar et al. Seizure. 2015 Dec; 33:88-9. View abstract
  125. Utility of initial EEG in first complex febrile seizure. Epilepsy Behav. 2015 Nov; 52(Pt A):200-4. View abstract
  126. Treatment of electrical status epilepticus in sleep: A pooled analysis of 575 cases. Epilepsia. 2015 Nov; 56(11):1738-46. View abstract
  127. Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors. Epilepsia. 2015 Oct; 56(10):1599-604. View abstract
  128. Should epileptiform discharges be treated? Epilepsia. 2015 Oct; 56(10):1492-504. View abstract
  129. Outcomes in pediatric patients with nonconvulsive status epilepticus. Epilepsy Behav. 2015 Aug; 49:98-103. View abstract
  130. Acute seizure suppression by transcranial direct current stimulation in rats. Ann Clin Transl Neurol. 2015 Aug; 2(8):843-56. View abstract
  131. Autonomic changes following generalized tonic clonic seizures: An analysis of adult and pediatric patients with epilepsy. Epilepsy Res. 2015 Sep; 115:113-8. View abstract
  132. Seizures and brain regulatory systems: consciousness, sleep, and autonomic systems. J Clin Neurophysiol. 2015 Jun; 32(3):188-93. View abstract
  133. Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015 Jun 09; 84(23):2304-11. View abstract
  134. Therapeutic choices in convulsive status epilepticus. Expert Opin Pharmacother. 2015 Mar; 16(4):487-500. View abstract
  135. Pediatric refractory epilepsy: A decision analysis comparing medical versus surgical treatment. Epilepsia. 2015 Feb; 56(2):263-72. View abstract
  136. Autonomic changes in psychogenic nonepileptic seizures: toward a potential diagnostic biomarker? Clin EEG Neurosci. 2015 Jan; 46(1):16-25. View abstract
  137. Clinical and Neuroimaging Profile of Children with Lesions in the Corpus Callosum. J Neuroimaging. 2015 Sep-Oct; 25(5):824-31. View abstract
  138. Pediatric status epilepticus management. Curr Opin Pediatr. 2014 Dec; 26(6):668-74. View abstract
  139. Febrile status epilepticus: time is of the essence. Epilepsy Curr. 2014 Nov-Dec; 14(6):345-7. View abstract
  140. Development and validation of a seizure prediction model in critically ill children. Seizure. 2015 Feb; 25:104-11. View abstract
  141. Passive fMRI mapping of language function for pediatric epilepsy surgical planning: validation using Wada, ECS, and FMAER. Epilepsy Res. 2014 Dec; 108(10):1874-88. View abstract
  142. Subunit composition of neurotransmitter receptors in the immature and in the epileptic brain. Biomed Res Int. 2014; 2014:301950. View abstract
  143. Seizure detection, seizure prediction, and closed-loop warning systems in epilepsy. Epilepsy Behav. 2014 Aug; 37:291-307. View abstract
  144. Localization of sleep spindles, k-complexes, and vertex waves with subdural electrodes in children. J Clin Neurophysiol. 2014 Aug; 31(4):367-74. View abstract
  145. Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience. Epilepsia. 2014 Aug; 55(8):1235-44. View abstract
  146. Management of pediatric status epilepticus. Curr Treat Options Neurol. 2014 Jul; 16(7):301. View abstract
  147. Comparison of pediatric patients with status epilepticus lasting 5-29 min versus =30 min. Epilepsy Behav. 2014 Aug; 37:1-6. View abstract
  148. Copy number variation plays an important role in clinical epilepsy. Ann Neurol. 2014 Jun; 75(6):943-58. View abstract
  149. Treatment for continuous spikes and waves during sleep (CSWS): survey on treatment choices in North America. Epilepsia. 2014 Jul; 55(7):1099-108. View abstract
  150. Comparison of risk factors for pediatric convulsive status epilepticus when defined as seizures = 5 min versus seizures = 30 min. Seizure. 2014 Oct; 23(9):692-8. View abstract
  151. Pediatric status epilepticus: how common is cerebrospinal fluid pleocytosis in the absence of infection? Seizure. 2014 Aug; 23(7):573-5. View abstract
  152. Predicting diurnal and sleep/wake seizure patterns in paediatric patients of different ages. Epileptic Disord. 2014 Mar; 16(1):56-66. View abstract
  153. Subunit composition of glutamate and gamma-aminobutyric acid receptors in status epilepticus. Epilepsy Res. 2014 May; 108(4):605-15. View abstract
  154. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy. Pediatr Neurol. 2014 Jul; 51(1):60-6. View abstract
  155. Development and implementation of a quality improvement curriculum for child neurology residents: lessons learned. Pediatr Neurol. 2014 May; 50(5):452-7. View abstract
  156. Diagnostic delays in children with early onset epilepsy: impact, reasons, and opportunities to improve care. Epilepsia. 2014 Jan; 55(1):123-32. View abstract
  157. Electrocorticography for seizure foci mapping in epilepsy surgery. J Clin Neurophysiol. 2013 Dec; 30(6):554-70. View abstract
  158. Electrographic seizures after convulsive status epilepticus in children and young adults: a retrospective multicenter study. J Pediatr. 2014 Feb; 164(2):339-46.e1-2. View abstract
  159. Outcomes of vagal nerve stimulation in a pediatric population: a single center experience. Seizure. 2014 Feb; 23(2):105-11. View abstract
  160. Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG). Seizure. 2014 Feb; 23(2):87-97. View abstract
  161. Long-term response to high-dose diazepam treatment in continuous spikes and waves during sleep. Pediatr Neurol. 2013 Sep; 49(3):163-170.e4. View abstract
  162. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia. 2013 Oct; 54(10):1753-60. View abstract
  163. The diagnostic yield of pediatric polysomnography based on the professional background of referring physicians. Clin Pediatr (Phila). 2013 Dec; 52(12):1154-60. View abstract
  164. Priorities in pediatric epilepsy research: improving children's futures today. Neurology. 2013 Sep 24; 81(13):1166-75. View abstract
  165. Continuous Spikes and Waves during Sleep: Electroclinical Presentation and Suggestions for Management. Epilepsy Res Treat. 2013; 2013:583531. View abstract
  166. Electroencephalography monitoring in critically ill children: current practice and implications for future study design. Epilepsia. 2013 Aug; 54(8):1419-27. View abstract
  167. Electrode localization for planning surgical resection of the epileptogenic zone in pediatric epilepsy. Int J Comput Assist Radiol Surg. 2014 Jan; 9(1):91-105. View abstract
  168. Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology. 2013 Jul 23; 81(4):383-91. View abstract
  169. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013 Aug; 54(8):1498-503. View abstract
  170. Visual aids to medical data and computational diagnostics: new frontiers in pediatric neurology. Epilepsy Behav. 2013 Aug; 28(2):258-60. View abstract
  171. Management of childhood epilepsy. Continuum (Minneap Minn). 2013 Jun; 19(3 Epilepsy):656-81. View abstract
  172. Predictors of seizure occurrence in children undergoing pre-surgical monitoring. Seizure. 2013 Oct; 22(8):640-6. View abstract
  173. Electroencephalography in the pediatric emergency department: when is it most useful? J Child Neurol. 2014 Apr; 29(4):475-82. View abstract
  174. Clinical practice guidelines and practice parameters for the child neurologist. J Child Neurol. 2013 Jul; 28(7):917-25. View abstract
  175. Cardiopulmonary complications during pediatric seizures: a prelude to understanding SUDEP. Epilepsia. 2013 Jun; 54(6):1083-91. View abstract
  176. Chronopharmacology of anti-convulsive therapy. Curr Neurol Neurosci Rep. 2013 Apr; 13(4):339. View abstract
  177. Pediatric ICU EEG monitoring: current resources and practice in the United States and Canada. J Clin Neurophysiol. 2013 Apr; 30(2):156-60. View abstract
  178. Should readmission within 30 days after discharge of children hospitalized for a neurologic disorder be considered a quality assurance failure? J Child Neurol. 2013 Jun; 28(6):758-61. View abstract
  179. Electroencephalographic monitoring in the pediatric intensive care unit. Curr Neurol Neurosci Rep. 2013 Mar; 13(3):330. View abstract
  180. Sturge-Weber syndrome: clinical and radiological correlates in 86 patients. Ideggyogy Sz. 2013 Jan 30; 66(1-2):53-7. View abstract
  181. Automated quantification of spikes. Epilepsy Behav. 2013 Feb; 26(2):143-52. View abstract
  182. Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol. 2012 Dec; 47(6):390-410. View abstract
  183. The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia. 2013 Apr; 54(4):741-50. View abstract
  184. Risk factors associated with death in in-hospital pediatric convulsive status epilepticus. PLoS One. 2012; 7(10):e47474. View abstract
  185. Clinical evolution of seizures: distribution across time of day and sleep/wakefulness cycle. J Neurol. 2013 Feb; 260(2):549-57. View abstract
  186. Pediatric focal epilepsy syndromes. J Clin Neurophysiol. 2012 Oct; 29(5):425-40. View abstract
  187. Dacrystic seizures: demographic, semiologic, and etiologic insights from a multicenter study in long-term video-EEG monitoring units. Epilepsia. 2012 Oct; 53(10):1810-9. View abstract
  188. Chrono-epileptology: time to reconsider seizure timing. Seizure. 2012 Jul; 21(6):411. View abstract
  189. Overcoming barriers to successful epilepsy management. Epilepsy Curr. 2012 Jul; 12(4):158-60. View abstract
  190. Circadian patterns of generalized tonic-clonic evolutions in pediatric epilepsy patients. Seizure. 2012 Sep; 21(7):535-9. View abstract
  191. Effect of treatment of obstructive sleep apnea on seizure outcomes in children with epilepsy. Pediatr Neurol. 2012 Jun; 46(6):359-62. View abstract
  192. Diurnal and sleep/wake patterns of epileptic spasms in different age groups. Epilepsia. 2012 Jul; 53(7):1170-7. View abstract
  193. Clinical staging and electroencephalographic evolution of continuous spikes and waves during sleep. Epilepsia. 2012 Jul; 53(7):1185-95. View abstract
  194. Outcomes of epileptic spasms in patients aged less than 3 years: single-center United States experience. Pediatr Neurol. 2012 May; 46(5):276-80. View abstract
  195. Short-term response of sleep-potentiated spiking to high-dose diazepam in electric status epilepticus during sleep. Pediatr Neurol. 2012 May; 46(5):312-8. View abstract
  196. Early thalamic lesions in patients with sleep-potentiated epileptiform activity. Neurology. 2012 May 29; 78(22):1721-7. View abstract
  197. Autonomic changes with seizures correlate with postictal EEG suppression. Neurology. 2012 Jun 05; 78(23):1868-76. View abstract
  198. Patients with electrical status epilepticus in sleep share similar clinical features regardless of their focal or generalized sleep potentiation of epileptiform activity. J Child Neurol. 2013 Jan; 28(1):83-9. View abstract
  199. Convulsive seizure detection using a wrist-worn electrodermal activity and accelerometry biosensor. Epilepsia. 2012 May; 53(5):e93-7. View abstract
  200. Analysis of EEG patterns and genotypes in patients with Angelman syndrome. Epilepsy Behav. 2012 Mar; 23(3):261-5. View abstract
  201. Behavioral measures and EEG monitoring using the Brain Symmetry Index during the Wada test in children. Epilepsy Behav. 2012 Mar; 23(3):247-53. View abstract
  202. Signal subspace integration for improved seizure localization. Annu Int Conf IEEE Eng Med Biol Soc. 2012; 2012:1016-9. View abstract
  203. Epileptic syndromes with focal seizures of childhood and adolescence. Handb Clin Neurol. 2012; 107:195-208. View abstract
  204. An electroencephalographic recording platform for real-time seizure detection. Annu Int Conf IEEE Eng Med Biol Soc. 2012; 2012:875-8. View abstract
  205. Treatment of pediatric status epilepticus. Curr Treat Options Neurol. 2011 Dec; 13(6):560-73. View abstract
  206. Teaching NeuroImages: mesial temporal sclerosis after a prolonged unprovoked seizure in an infant. Neurology. 2011 Nov 08; 77(19):e112-3. View abstract
  207. What is quality improvement and why should child neurologists care? J Child Neurol. 2012 Feb; 27(2):251-7. View abstract
  208. Outcome of no resection after long-term subdural electroencephalography evaluation in children with epilepsy. J Neurosurg Pediatr. 2011 Sep; 8(3):269-78. View abstract
  209. Selective serotonin reuptake inhibitors and periodic limb movements of sleep. Pediatr Neurol. 2011 Sep; 45(3):175-7. View abstract
  210. Necrotizing granulomatous meningoencephalitis due to Balamuthia in an immunocompetent child. Neurology. 2011 Aug 23; 77(8):801-2. View abstract
  211. Effect of continuous positive airway pressure treatment on seizure control in patients with obstructive sleep apnea and epilepsy. Epilepsia. 2011 Nov; 52(11):e168-71. View abstract
  212. Sleep-wake patterns of seizures in children with lesional epilepsy. Pediatr Neurol. 2011 Aug; 45(2):109-13. View abstract
  213. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol. 2011 Jun; 44(6):414-9. View abstract
  214. Electroencephalogram monitoring during intracranial surgery for moyamoya disease. Pediatr Neurol. 2011 Jun; 44(6):427-32. View abstract
  215. An empirical investigation of motion effects in eMRI of interictal epileptiform spikes. Magn Reson Imaging. 2011 Dec; 29(10):1401-9. View abstract
  216. Localization of pediatric seizure semiology. Clin Neurophysiol. 2011 Oct; 122(10):1924-8. View abstract
  217. Continuous spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol. 2011 Apr; 28(2):154-64. View abstract
  218. Chronobiology of epilepsy: diagnostic and therapeutic implications of chrono-epileptology. J Clin Neurophysiol. 2011 Apr; 28(2):146-53. View abstract
  219. Circadian distribution and sleep/wake patterns of generalized seizures in children. Epilepsia. 2011 Jun; 52(6):1076-83. View abstract
  220. Can semiology predict psychogenic nonepileptic seizures? A prospective study. Ann Neurol. 2011 Jun; 69(6):997-1004. View abstract
  221. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases. Epileptic Disord. 2011 Mar; 13(1):18-21. View abstract
  222. Rufinamide for the treatment of epileptic spasms. Epilepsy Behav. 2011 Feb; 20(2):344-8. View abstract
  223. Circadian patterns of pediatric seizures. Neurology. 2011 Jan 11; 76(2):145-53. View abstract
  224. Septo-optic dysplasia complicated by infantile spasms and bilateral choroidal fissure arachnoid cysts. J Neuroimaging. 2011 Jan; 21(1):89-91. View abstract
  225. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav. 2011 Feb; 20(2):334-7. View abstract
  226. Incidence and clinical decision making for the Wada test over one decade: 1997-2007. Epileptic Disord. 2010 Dec; 12(4):249-54. View abstract
  227. Experience with rufinamide in a pediatric population: a single center's experience. Pediatr Neurol. 2010 Sep; 43(3):155-8. View abstract
  228. Surgical treatment of refractory status epilepticus in children: candidate selection and outcome. Semin Pediatr Neurol. 2010 Sep; 17(3):182-9. View abstract
  229. Fears and promises of comparative effectiveness research. Acta Paediatr. 2010 Sep; 99(9):1311-3. View abstract
  230. Clinical correlations of midline spikes in children. Epilepsy Behav. 2010 Aug; 18(4):460-5. View abstract
  231. Crying with left temporal lobe seizures and Wada testing. Epilepsy Behav. 2010 Jul; 18(3):303-5. View abstract
  232. Neuroimaging findings in children with benign focal epileptiform discharges. Epilepsy Res. 2010 Jun; 90(1-2):91-8. View abstract
  233. Visual naming performance after ATL resection: impact of atypical language dominance. Neuropsychologia. 2010 Jun; 48(7):2221-5. View abstract
  234. A self-administered screening instrument for psychogenic nonepileptic seizures. Neurology. 2010 Jan 19; 74(3):270; author reply 271. View abstract
  235. Continuous monitoring of electrodermal activity during epileptic seizures using a wearable sensor. Annu Int Conf IEEE Eng Med Biol Soc. 2010; 2010:4415-8. View abstract
  236. Childhood absence epilepsy in patients with benign focal epileptiform discharges. Pediatr Neurol. 2009 Dec; 41(6):428-34. View abstract
  237. Language assessment in Wada test: comparison of methohexital and amobarbital. Seizure. 2009 Nov; 18(9):656-9. View abstract
  238. Longer duration of epilepsy and earlier age at epilepsy onset correlate with impaired cognitive development in infancy. Epilepsy Behav. 2009 Nov; 16(3):431-5. View abstract
  239. Memory performance is related to language dominance as determined by the intracarotid amobarbital procedure. Epilepsy Behav. 2009 Sep; 16(1):145-9. View abstract
  240. Holocord spinal epidural abscess. J Child Neurol. 2009 Jun; 24(6):768-71. View abstract
  241. A self-administered screening instrument for psychogenic nonepileptic seizures. Neurology. 2009 May 12; 72(19):1646-52. View abstract
  242. Atypical language lateralization in epilepsy patients. Epilepsia. 2009 Jun; 50(6):1505-16. View abstract
  243. Epilepsy surgery in children with electrical status epilepticus in sleep. Neurosurgery. 2009 Feb; 64(2):328-37; discussion 337. View abstract
  244. Epilepsy surgery in epidermal nevus syndrome variant with hemimegalencephaly and intractable seizures. J Neurol. 2008 Nov; 255(11):1829-31. View abstract
  245. Lateralizing value of epileptic nystagmus. Epilepsy Behav. 2008 Nov; 13(4):700-2. View abstract
  246. Complications during the Wada test. Epilepsy Behav. 2008 Oct; 13(3):551-3. View abstract
  247. Quo vadis Wada? Epilepsy Behav. 2008 Jul; 13(1):1-2. View abstract
  248. Discontinuation of medications after successful epilepsy surgery in children. Pediatr Neurol. 2008 May; 38(5):340-4. View abstract
  249. Pituitary stalk duplication in association with moya moya disease and bilateral morning glory disc anomaly - broadening the clinical spectrum of midline defects. J Neurol. 2008 Jun; 255(6):885-90. View abstract
  250. Lateralization of interictal EEG findings. J Clin Neurophysiol. 2007 Oct; 24(5):379-85. View abstract
  251. Risk factors for early visual deterioration in temporal arteritis. J Neurol Neurosurg Psychiatry. 2007 Nov; 78(11):1255-9. View abstract
  252. Developmental outcome after epilepsy surgery in infancy. Pediatrics. 2007 May; 119(5):930-5. View abstract
  253. Repeated intracarotid amobarbital tests. Epilepsia. 2007 Mar; 48(3):553-8. View abstract
  254. Seizures during intracarotid methohexital and amobarbital testing. Epilepsy Behav. 2007 Feb; 10(1):49-54. View abstract
  255. Index of suspicion. Pediatr Rev. 2006 Sep; 27(9):351-7. View abstract
  256. [Suggestion for a new, patient-oriented epilepsy classification]. Nervenarzt. 2006 Aug; 77(8):961-9. View abstract
  257. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure. 2006 Oct; 15(7):491-503. View abstract
  258. Double-blind, randomized controlled study of bilateral cerebellar stimulation. Epilepsia. 2006 Jul; 47(7):1247; author reply 1248-9. View abstract
  259. Intracranial lipomas and epilepsy. J Neurol. 2006 May; 253(5):590-3. View abstract
  260. Are epilepsy classifications based on epileptic syndromes and seizure types outdated? Epileptic Disord. 2006 Mar; 8(1):81-5. View abstract
  261. A proposal for a five-dimensional patient-oriented epilepsy classification. Epileptic Disord. 2005 Dec; 7(4):308-16. View abstract
  262. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy. Epilepsia. 2005 Oct; 46(10):1654-60. View abstract
  263. Lateralizing signs during seizures in focal epilepsy. Epilepsy Behav. 2005 Aug; 7(1):1-17. View abstract
  264. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology. 2005 Mar 22; 64(6):1086-7. View abstract
  265. Acute repetitive pilomotor seizures. Clin Neurophysiol. 2005 Apr; 116(4):989-90; author reply 990. View abstract
  266. Temporal arteritis. 1932. Arch Neurol. 2004 Oct; 61(10):1620-2. View abstract
  267. Mononeuropathy of the laryngeal recurrent nerve as possible manifestation of human immunodeficiency virus infection. Otolaryngol Head Neck Surg. 2004 Oct; 131(4):556-7. View abstract
  268. Validity of language lateralisation by unilateral intracarotid Wada test. J Neurol Neurosurg Psychiatry. 2004 Sep; 75(9):1367; author reply 1367-8. View abstract
  269. Lateralizing signs during seizures in infants. J Neurol. 2004 Sep; 251(9):1075-9. View abstract
  270. Localising and lateralising value of ictal piloerection. J Neurol Neurosurg Psychiatry. 2004 Jun; 75(6):879-83. View abstract
  271. Non-epileptic seizures of the elderly. J Neurol. 2004 Jun; 251(6):704-9. View abstract
  272. Specific epileptic syndromes are rare even in tertiary epilepsy centers: a patient-oriented approach to epilepsy classification. Epilepsia. 2004 Mar; 45(3):268-75. View abstract
  273. Seizure semiology in the elderly: a video analysis. Epilepsia. 2004 Mar; 45(3):263-7. View abstract
  274. Aphasia after hemispherectomy in an adult with early onset epilepsy and hemiplegia. J Neurol Neurosurg Psychiatry. 2004 Jan; 75(1):149-51. View abstract
  275. Stool-withholding activity mimicking epilepsy. Neurology. 2003 Nov 25; 61(10):1454-5. View abstract
  276. Ictal spitting: clinical and electroencephalographic features. Epilepsia. 2003 Aug; 44(8):1064-9. View abstract
  277. [Electric brain stimulation for epilepsy therapy]. Nervenarzt. 2003 Aug; 74(8):664-76. View abstract
  278. Epileptic monocular nystagmus. Neurology. 2003 Jul 08; 61(1):145-7; author reply 147. View abstract
  279. Late language transfer in patients with Rasmussen encephalitis. Epilepsia. 2003 Jun; 44(6):870-1. View abstract
  280. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology. 2003 Mar 11; 60(5):885-6; author reply 885-6. View abstract
  281. Ictal urinary urge: further evidence for lateralization to the nondominant hemisphere. Epilepsia. 2003 Jan; 44(1):124-6. View abstract
  282. Carotid artery dissection after the intracarotid amobarbital test. Neurology. 2002 Dec 10; 59(11):1797-8. View abstract
  283. Neurological manifestations of the oculodentodigital dysplasia syndrome. J Neurol. 2002 May; 249(5):584-95. View abstract
  284. Deep brain stimulation in epilepsy. J Clin Neurophysiol. 2001 Nov; 18(6):514-32. View abstract
  285. [Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile]. Nervenarzt. 2001 Oct; 72(10):764-9. View abstract